Introduction
Synovial joints are essential for the biomechanical function of the skeleton. As improper function, as observed in arthritic diseases, directly results in a severe loss of life quality, joint biology has been in focus of extensive research for years leading to an understanding of joint anatomy and histology as well as the biomechanical properties and roles of articular cartilage and other components in joint function and maintenance. However, little is known about how synovial joints acquire their structure in the developing embryo and in particular what factors are required for the differentiation of progenitor cells, which then give rise to each joint component (Pacifici et al, 2005) . As a first sign of joint formation in the embryonic limb, an emergence of a mesenchymal interzone at each prospective joint site can be observed (Holder, 1977; Mitrovic, 1978) . This interzone is a tripartite tissue structure composed of an intermediate cell layer and two outer cell layers with higher cell density. Interzone cells express a number of genes being involved in chondrogenesis such as Wnt-9a, Wnt-4, Noggin and growth and differentiation factor 5 (GDF-5) (Storm et al, 1994; Brunet et al, 1998; Hartmann and Tabin, 2001) .
GDF-5, a member of the large TGF-b superfamily of secreted growth factors, shows chondrogenic activity and congenital GDF-5 mutations cause defects in digit, wrist and ankle joints in mice and humans (Storm et al, 1994; Thomas et al, 1997) . The expression of GDF-5 is most strikingly limited to regions where joints will develop and is one of the earliest markers of joint formation (Storm and Kingsley, 1999) . Similar to other TGF-b superfamily members, GDF-5 binds to and oligomerizes two types of membrane bound serine-threonine kinase receptors termed type I and II. Upon ligand binding, these complexes transduce signals by phosphorylating members of the SMAD family of transcription factors, which upon activation enter the nucleus and regulate transcription of responsive genes (Massague, 1996) . Recent experiments have implicated two different type I receptors in skeletal patterning, BMPR-IA and BMPR-IB. Both receptors are expressed in dynamic patterns during normal development. In several limb structures, for example, in joint interzones and perichondrium, an overlapping expression of BMPR-IA and BMPR-IB is observed (Mishina et al, 1995; Zou et al, 1997; Baur et al, 2000) . With regard to the BMPR-IA and BMPR-IB expression patterns, GDF-5 signal transduction should be accomplished by the interaction with both BMPR-IA and BMPR-IB (Chang et al, 1994; Zou et al, 1997) . Null mutations in the bmpr-1b gene produce viable mice with defects in bone and joint formation that closely resemble those seen in mice missing GDF-5 (Storm and Kingsley, 1996; Yi et al, 2000) , whereas bmpr-ia À/À mice are known to die early in embryogenesis (Mishina et al, 1995) . However, a conditional knockout of BMPR-IA under the control of a GDF5-Cre driver bypasses embryonic lethality and produces viable mice with normally formed joints. But, after birth articular cartilage within the joints wears away in a process reminiscent to osteoarthritis, which points at the importance of this receptor in cartilage homoeostasis and repair (Rountree et al, 2004) . In the past, several single missense mutations in the mature part of the human GDF-5 have been described resulting in phenotypes such as brachydactyly A2 (BDA2), DuPan syndrome and symphalangism type I (SYM1) (for details, see Supplementary Table I) . Interestingly, the majority of phenotypically relevant mutations occur within a central loop (prehelix loop) of the so-called wrist epitope of GDF-5 that represents the binding site for BMP type I receptors. The corresponding pre-helix loop in BMP-2 harbours the main binding determinants for type I receptor interaction. In contrast to BMP-2, which binds BMPR-IA and BMPR-IB with almost identical affinities (K D B1-3 nM), GDF-5 binds BMPR-IB in vitro with about 10-to 20-fold higher affinity (K D B1-2 nM) as compared with BMPR-IA (K D B15-20 nM). A mutagenesis study revealed that a single residue in GDF-5 located in the pre-helix loop, Arg57, solely determines the binding specificity for the BMP type I receptor IB .
To date, neither the structure of GDF-5 bound to BMPR-IA nor to BMPR-IB has been reported. Only structure data for the unbound GDF-5 Schreuder et al, 2005) and other TGF-b members such as BMP-2 (Kirsch et al, 2000b; Keller et al, 2004; Allendorph et al, 2006; Weber et al, 2007) , BMP-7 (Greenwald et al, 2003) , activin-A (Thompson et al, 2003) or TGF-b3 (Hart et al, 2002; Groppe et al, 2008) in complex with either receptor subtype are currently available. A theoretical model for GDF-5 ligandreceptor complex based on these data has, however, failed to explain type I receptor specificity of GDF-5 . Here, we present the crystal structure of GDF-5 bound to BMPR-IB allowing the deduction of mechanisms by which type I receptor specificity is encoded on a molecular level. Furthermore, these structural data allow for the first time an understanding of how phenotypically relevant missense mutations found in GDF-5 impair receptor binding and activation.
Results
Architecture of the complex of GDF-5 and its highaffinity type I receptor BMPR-IB The crystal structure of the binary complex GDF-5 bound to the extracellular domain of BMPR-IB was determined to 2.1 Å resolution. The final structure model was obtained by refining native data (R merge is 7.1% for all reflections and 35.4% for those in the highest resolution shell) and exhibits an R free of 25.6% and an R cryst of 21.5% (for further processing and refinement statistics, see Table I ). The asymmetric unit contains one GDF-5 monomer with one BMPR-IB ectodomain bound, thus the biological assembly is formed by a two-fold crystallographic symmetry axis resulting in a fully symmetrical dimer assembly. The GDF-5 dimer exhibits a butterfly-shaped architecture, with a central core formed by the cystine-knot flanked by the two a-helices from each monomer. Two b-sheets comprised of four strands each form the two fingers per monomeric GDF-5 subunit. Four receptor-binding sites exist in the GDF-5 dimer, the type II receptor sites (knuckle) are located at the back of the two fingers, whereas the type I receptor-binding sites (wrist) are located in the cleft between the helix a1 of one monomer and the front side of the fingers 1 and 2 of the other monomer. The two BMPR-IB molecules in the complex bind to the wrist epitopes of GDF-5 (Figure 1) , resembling a similar ligandreceptor assembly as also found for BMP-2 when bound to BMPR-IA (Kirsch et al, 2000b; Keller et al, 2004) . However, closer inspection reveals clear differences, with the BMPR-IB moved upward by almost 2 Å compared with the complex BMP-2:BMPR-IA (Figure 1 ). This coincides with a change in the tilt angle of about 91 when comparing a single receptor One crystal was used to collect the diffraction data. (Groppe et al, 2008) , it clearly shows that the location and orientation of the receptor ectodomains in the ligand-binding sites of different BMPs can vary.
The structure of the binding loop of BMPR-IB differs from that of BMPR-IA Our complex structure GDF-5:BMPR-IB now yields data for a BMP type I receptor ectodomain other than BMPR-IA and thus allows to detect structural differences and variability among BMP type I receptors. The ectodomain of BMPR-IB shares about 50% identity on amino-acid sequence level with BMPR-IA (Supplementary Figure 1) . Therefore, many of the secondary structure elements and the tertiary fold are conserved between BMPR-IB and BMPR-IA (Figure 1 ). However, a detailed comparison of the structures of both receptor ectodomains reveals some structural differences between BMPR-IB and BMPR-IA (PDB entry 1REW). The structural core comprising five b-strands superimposes well showing an r.m.s.d. of 0.7 Å , but considering all Ca in the ectodomains the r.m.s.d. rises to 2.2 Å , showing that the loop sections differ significantly between BMPR-IB and BMPR-IA. As binding and recognition by GDF-5 are mainly mediated through the b1b2 and the a1b5 loops of BMPR-IB this is of important biological consequence. Taken together, both loops contribute almost 80% of the buried surface area of the BMPR-IB ectodomain in the complex. These loops show large structural differences between BMPR-IB and BMPR-IA with Ca positions being shifted up to 3 Å in the b1b2 loop and up to 5 Å in the a1b5 loop. Thus, the binding determinants of the GDF-5:BMPR-IB and BMP-2:BMPR-IA (PDB entry 1REW) complexes likely differ not only due to the different orientations of the type I receptor ectodomains but also due to the differences present in the binding loops of BMPR-IB and BMPR-IA. Notably, the length of the a-helix, which carries the hot spot of binding for the BMP-2:BMPR-IA interaction, also varies between BMPR-IB and BMPR-IA. In BMPR-IA, the a-helix comprises residues Ser83 to Lys88 and hence has a length of more than 1.6 turns. In BMPR-IB, the a-helix is two residues shorter (Ser64 to Gln67) and consists of just one turn. The GDF-5-type I receptor interaction in the GDF-5:BMPR-IB complex About 1040 Å 2 solvent accessible surface of the BMP type IB receptor (for one receptor ectodomain of the dimeric assembly) and 1100 Å 2 solvent accessible surface of GDF-5 (per type I receptor-binding site) are buried upon complex formation. Thus, considering the dimeric assembly with two BMPR-IB and two GDF-5 wrist epitopes involved, about 4280 Å 2 of the protein surfaces are buried upon binding of GDF-5 to two BMPR-IB. Here, 22 residues of BMPR-IB (per molecule) and 21 residues of GDF-5 (per monomeric subunit) mark the contact interface. Of the 22 contact residues of BMPR-IB and the 21 contact residues of GDF-5 in the GDF-5:BMPR-IB interface, 15 are conserved with BMPR-IA and 13 are conserved with BMP-2 in the BMP-2:BMPR-IA interface (Figure 2 ). Nine intermolecular hydrogen bonds (H-bonds) are observed in the GDF-5:BMPR-IB contact (Supplementary Table II) . Five of these involve residues in helix a1 and the a1b5 loop of BMPR-IB, suggesting that these elements are highly important for ligand recognition and binding. Interestingly, the bi-dentate H-bond between the conserved glutamine in helix a1 of the type I receptor (BMPR-IB:Gln67; BMPR-IA:Gln86) and the main chain polar groups of a conserved leucine in the pre-helix loop of the ligand (GDF-5 Leu56; BMP-2 Leu51) is also present in the GDF-5:BMPR-IB contact. However, whether this H-bond, similar as for the BMP-2:BMPR-IA interaction (Keller et al, 2004) , presents the hot spot of binding for the GDF-5:BMPR-IB complex cannot be told from the structure.
Therefore, Gln67 and Phe66 in BMPR-IB were mutated to alanine, and their binding to GDF-5 and BMP-2, was tested by SPR. Surprisingly, the surmised hot spot of binding Gln67 showed only slightly decreased affinities for GDF-5 (6.3-fold) and BMP-2 (4.5-fold), respectively (Table II) . Thus, in contrast to BMPR-IA, where the mutation BMPR-IAQ86A leads to almost 100-fold loss in affinity for BMP-2 (Keller et al, 2004) , the conserved glutamine does not represent a hot spot of binding for BMPR-IB. Exchange of Phe66 in BMPR-IB by alanine, however, almost completely abolished binding to GDF-5 and BMP-2. Hatta et al (2000) observed that the affinity of the BMPR-IA variant F85A is decreased for BMP-2 only 15-fold (DDG ¼ 1.5 kcal mol À1 ), suggesting that Phe85 is not a hot spot of binding in the BMP-2:BMPR-IA interaction. Thus, the conserved phenylalanine is crucial only for binding of BMPR-IB to BMPs, whereas the conserved glutamine seems important only for binding of BMPR-IA to the ligands. These findings corroborate our hypothesis that recognition and binding of BMPR-IB to BMPs differ from BMPR-IA.
GDF-5 passes through an induced fit upon complex formation
Comparison of free GDF-5 and GDF-5 bound to BMPR-IB shows that GDF-5 passes through an induced fit upon complex formation. Both fingers of GDF-5 move towards BMPR-IB upon binding, indicating that the opening of the wrist epitope is wider in the free form and upon BMPR-IB binding the fingers 'wrap around' BMPR-IB to make packing tighter (Figure 3) .
The finger 2 of GDF-5 moves as a rigid body with the side chains being pre-oriented in the free form. In contrast, in finger 1 of GDF-5 several side chains move significantly. In unbound GDF-5, Trp36 is pointing away from the receptorbinding epitope. In the complex, the Trp36 points towards the receptor, with the side chain atoms moving by almost 8 Å (Figure 3) . These large rearrangements in the ligand are not observed in the BMP-2:BMPR-IA complex formation. In BMP-2, the movements in fingers 1 and 2 are less than 2 Å with the side chains being pre-oriented before receptor binding. The GDF-5 pre-helix loop also rearranges upon BMPR-IB binding. The changes in Ca position are comparable to those in BMP-2 upon binding to BMPR-IA (free BMP-2: 3BMP; bound BMP-2: 1REW).
On the basis of its homology to BMPR-IA, we also think that BMPR-IB passes through an induced fit mechanism upon ligand binding. NMR studies on the extracellular domain of free BMPR-IA showed that the b1b2-and especially the b4b5-loops are highly flexible and disordered in solution (Klages et al, 2008) . Helix a1 is absent in free BMPR-IA (PDB entry 2K3G). As the helix of bound BMPR-IB is even shorter compared with BMPR-IA and thus probably less stable, this loop segment is likely similarly flexible in free BMPR-IB. Thus, both complex partners bind by an induced fit mechanism, which possibly represents a molecular mechanism to generate specificity as well as promiscuity.
The BMPR-IB specificity of GDF-5 is based on a spring-loaded latch in BMPR-IB In contrast to BMP-2, GDF-5 is described to have a pronounced type I receptor specificity in vivo (Nishitoh et al, 1996) . In vitro, type I receptor discrimination of GDF-5 seems less dramatic with respect to affinities for BMPR-IB (K D 1.3 nM) and BMPR-IA (K D 16.2 nM), showing that only a factor of 10-20 is sufficient for discrimination between BMPR-IB and BMPR-IA . However, even this supposedly small difference is of great physiological significance for GDF-5 function in vivo as can be seen from the R57L mutation (R438L pro-protein numbering). The mutant GDF-5R57L exhibits an enhanced affinity for BMPR-IA (K D 4.2 nM) and nearly unaltered binding to BMPR-IB (K D 0.7 nM) (Table III) . This correlates with the mutation of Arg57 to alanine that abrogates type I receptor specificity of GDF-5 completely . Therefore, the mechanism encoding for BMPR-IB specificity should be in close proximity of GDF-5 Arg57. In the complex structure, GDF-5 Arg57 is completely hidden inside the ligand-receptor interface and shares contact with several residues of BMPR-IB. This is in contrast to the modelling studies, that suggested Arg57 pointing away from the interface out into the solvent ).
During refinement, two alternative conformations were detected for the b1b2 loop of BMPR-IB. As there is only one receptor ectodomain in the asymmetric unit-the full tetrameric GDF-5:(BMPR-IB) 2 complex is formed by a two-fold crystallographic axis-both conformations are observed in the same BMPR-IB molecule (Figure 4 ). In the 'closed' conformer, the b1b2 loop of BMPR-IB contacts Arg57, with the Arg side chain being clamped between the aromatic ring of Arg57 towards the solvent. This movement is due to a 1801 flip in the Psi torsion angle of His22 resulting in an altered backbone route for BMPR-IB His23 and His24 (Supplementary Figure 3) . The Ca atoms of the latter histidines relocate by 2.3 Å , possibly allowing water to fill the cleft nearby GDF-5 Arg57. The side chain conformation of Arg57 is unchanged in both conformations. As at the resolution of 2.1 Å , it is not reasonable to do occupancy refinement, the (Wallace et al, 1995) analysis of the GDF-5:BMPR-IB interface. H-bonds are indicated as stippled lines with the residues involved shown as ball-and-stick models. Hydrophobic contacts are presented as spheres; the buried surface area of each contact residue is given in Å 2 (boxed values below residues). Only hydrophobic contacts with buried surface areas X5 Å 2 are shown. (B) 'Open book' view of the GDF-5:BMPR-IB complex with BMPR-IB rotated out of the interface by a 1201 rotation in the y axis. The surface is colour coded by amino-acid polarity; red marks negatively charged residues, blue positively charged residues, green indicates polar uncharged amino acids and grey colour represents hydrophobic amino acids. Contact residues are indicated by residue number and amino-acid type in one-letter code. The contact surface of BMPR-IA in the BMP-2:BMPR-IA complex (PDB entry 1REW) is given for comparison.
relative populations for both conformers can be estimated only from the electron density, suggesting that both conformations are roughly equally populated.
The local conformational change in the b1b2 loop possibly results from fixing the segment His22 to His24 in between the disulphide bond Cys21-Cys25. In the resulting pre-stressed loop, resembling a pentameric cyclic peptide, backbone torsion angle space in the N-terminal section of the b1b2 loop is limited to a few allowed states. In BMPR-IA, His23 is replaced by a glycine. This exchange probably removes the tension on the backbone between the conserved disulphide. Indeed, BMPR-IA Gly42 (His23 BMPR-IB) exhibits backbone torsion angles that are not amenable to non-glycine residues (Supplementary Figure 3) . Thus, docking of the BMPR-IA ectodomain onto the GDF-5:BMPR-IB complex shows that the BMPR-IA b1b2 loop (Cys40-Cys44) would move towards the pre-helix loop of GDF-5 (using the above terminology, the b1b2 loop would then adopt a locked conformation). This cleft is, however, occupied by Arg57 leading to a steric clash and possibly explaining the lower binding affinity of GDF-5 for BMPR-IA (Figure 4) . Therefore, discrimination between BMPR-IB and BMPR-IA by GDF-5 might be based on a molecular latch mechanism, in which a receptor loop is 'actively' moved away from a bulky residue in GDF-5; the type I receptor with lower affinity-BMPR-IA-has a mutation that removes the spring from this latch. Consequently, substitution of Arg57 in GDF-5 by smaller, less bulky residues increases the affinity to BMPR-IA by removing the steric clash. The fact that the GDF-5 mutations R57L and R57A do not lower the affinity for BMPR-IB Seemann et al, 2005) (Table III) despite the existence of two H-bonds between ligand and receptor can also be explained with the presence of the two conformations. Only one conformer allows the formation of the Hbonds, whereas the other conformer is open and water can fill in the cleft between Arg57 and the receptor loop. Thus, these two H-bonds are energetically silent due to entropy loss required for fixing the loop and the water molecules competing for intermolecular H-bond formation.
To test our hypothesis whether His23 controls the springlock mechanism, we have prepared the BMPR-IB variant H22S/H23G, in which the b1b2 loop between the two conserved cysteine residues reflects the situation found in BMPR-IA. However, SPR analysis of the BMPR-IB variant showed only a 3-to 4-fold reduced binding affinity for GDF-5 (K D 4.1 nM) and not the expected 10-to 20-fold decrease (Table II) . This suggests that additional factors might contribute to the BMPR-IB specificity of GDF-5; one possible source could be the difference in the tilt angle. The differences in the tilt angle of the type I receptor might also The apparent K D was estimated from the dose dependency of equilibrium binding and presents the lower limit due to technical limitations of the BIAcore2000 system. No binding above background levels could be detected, from the highest analyte concentration applicable in the analysis, the binding affinity was estimated to be X10 mM. The values for the apparent K D represent the lower limit estimated from the highest analyte concentration used in the SPR analysis. . Exchanges of or substitution by cysteines were considered to cause protein misfolding (Thomas et al, 1997; Everman et al, 2002) . The other mutations seem to be functional amino-acid exchanges and thus raise the question about their molecular mechanism in causing the disease. As no structural data are available for the GDF-5:type II receptor interaction, we focused on mutations affecting GDF-5:type I receptor interaction. Of the mutants described, three cluster in the type I receptor epitope, R57L (R438L pro-protein numbering), DL56/S58T/H59L (DL437/S439T/H440L proprotein numbering) and L60P (L441P pro-protein numbering) (Supplementary Table I) . For two variants, GDF-5L60P and GDF-5DL56/S58T/H59L (in the following GDF-5DP), type I receptor binding was either abrogated (GDF-5DP) or greatly decreased (GDF-5L60P) (Table III) . No induction of alkaline phosphatase (ALP) expression could be observed in cell-based assays ( Figure 5 ). Leu60 is also conserved in BMP-2 and exchange for proline does not seem to cause a steric clash internally or in the contact with BMPR-IB. Thus, the most likely explanation for the loss of binding is in a local structural rearrangement of the preceding pre-helix loop of GDF-5, which is involved in several H-bonds with BMPR-IB. The mutation GDF-5DP was recently described in patients suffering from DuPan syndrome (Szczaluba et al, 2005) and leads to a complete loss of binding to BMPR-IA and BMPR-IB (Table III) . As type II receptor binding seems to be not affected by the mutation, structural rearrangements are likely limited to the type I receptor epitope.
In contrast, exchange of Arg57 by leucine results in an enhanced affinity of GDF-5R57L to BMPR-IA (four-fold), whereas the affinity for BMPR-IB is almost unaltered (p2-fold) (Seemann et al, 2005) . In ALP assays, GDF-5R57L-similar to GDF-5R57A -exhibits a lower concentration required for 50% stimulation (EC 50 ) in both ATDC5 (Seemann et al, 2005) and RobC26 cells ( Figure 5 ). In ATDC5 cells, which lack BMPR-IB and signalling thus utilizes the BMPR-IA, the EC 50 is decreased from B30 nM for GDF-5 to 20 nM. In RobC26 cells, in which GDF-5 reportedly signals through BMPR-IB (Nishitoh et al, 1996; Erlacher et al, 1998) , a larger shift is observed in the EC 50 from 10 nM for GDF-5 to 1 nM for GDF-5R57L.
Additionally, we conducted reporter gene assays in ATDC5 cells and in the mouse fibroblast cell line C3H10T1/2 to directly measure SMAD1/5/8 activation. Consistent with the ALP assays, luciferase reporter activity is diminished for GDF-5L60P and GDF-5DP in both cell lines. Furthermore, the specificity impaired variant GDF-5R57L exhibits an enhanced activity in C3H10T1/2 cells and requires lower concentrations for half-maximal stimulation in ATDC5 cells ( Figure 5 ).
Discussion
Mutations in either GDF-5 or BMPR-IB leading to skeletal malformation diseases such as brachydactyly or symphalangism suggest that both proteins are functionally tightly coupled in vivo (Lehmann et al, 2003; Seemann et al, . Understanding how GDF-5 specifically interacts with BMPR-IB will thus yield important insights into the molecular mechanisms underlying those diseases. Although the complexes of GDF-5:BMPR-IB and BMP-2:BMPR-IA seem similar, numerous differences are observed. First, several regions in GDF-5 show considerable conformational rearrangements upon binding to BMPR-IB, whereas in BMP-2 a much smaller induced fit is observed only in a very limited area (Kirsch et al, 2000b; Keller et al, 2004) . As-based on the structure of free BMPR-IA (Klages et al, 2008) -also BMPR-IB probably passes through an induced fit upon complex formation, the epitopes of both interaction partners seem 'soft' and the final interface is developed when the complex is formed. The rearrangements seen in the GDF-5:BMPR-IB complex formation are on an intermediate level compared with the large changes in the ligand architecture observed for the TGF-b and activin-A ligand-receptor complexes on the one hand (Hart et al, 2002; Thompson et al, 2003) and the very rigid ligand architecture found in BMP-2/BMP-7 complexes on the other hand, in which the BMP ligands function as rather rigid clamps bringing type I and II receptors together (Kirsch et al, 2000b; Greenwald et al, 2003; Keller et al, 2004; Allendorph et al, 2006; Weber et al, 2007) . Second, the orientation of the BMPR-IB ectodomain differs from that of BMPR-IA in complex with BMP-2. Although the tilting of BMPR-IB in complex with GDF-5 compared with BMPR-IA in the BMP-2:BMPR-IA complex seems small (91), the relative orientation of the type I and II receptor kinase domains could change presuming that the complete receptor is 'rigid' and movements of the extracellular domain can propagate to the intracellular kinase domain. These small orientation differences now observed between different ligand-receptor complexes might explain how ligand-specific signals could be delivered by different BMP ligands, although the receptor composition of the complexes is identical. Koshland described different activation mechanisms (such as piston, rotation, see-saw and others) differing from the classical ligand-induced receptor oligomerization scheme, which allow single transmembrane receptors to activate and modulate intracellular signalling cascades (Ottemann et al, 1999) . Thus, orientation differences on the outside can be relayed through a single transmembrane segment and influence the inside signalling cascade.
Another difference between GDF-5 and BMP-2 is in the way type I receptor specificity and promiscuity are achieved. In BMP-2 interactions with type I receptors, side chain and backbone flexibility in the ligand and the receptor 'encode' for promiscuous binding by allowing adapting their surfaces to differing surface geometries. In the GDF-5:BMPR-IB complex investigated here, the flexibility of a loop can generate type I receptor specificity instead. The spring-loaded latch implemented in the BMPR-IB b1b2 loop seems required for high-affinity binding to GDF-5 by preventing a possible steric clash of this loop with the bulky Arg57 in GDF-5. In BMPR-IA, the 'spring' is removed therefore resulting in an altered, unfavourable conformation of this loop. The rearrangement of the receptor loop upon GDF-5:BMPR-IA interaction requires energy and thus binding affinity of GDF-5 for BMPR-IA is reduced. Trials to directly manipulate the latch by removal of the 'spring' residue His23 and replacing it with the corresponding Gly residue of BMPR-IA did, however, not show the maximal effect. One possible explanation might be in the differing orientation of both type I receptors in complexes with either GDF-5 or BMP-2, which could possibly influence the latch mechanism indirectly. Other mechanisms can also provide binding specificity in the TGF-b ligandreceptor interaction. For BMP-6, N-glycosylation of Asn73 in BMP-6 is required for binding to the activin type I receptor (ActR-I), whereas for binding to BMPR-IA or BMPR-IB presence of the carbohydrate moiety is dispensable (Saremba et al, 2008) . In BMP-2, activation of a silent H-bond in the type II receptor epitope confers high binding affinity specifically to ActR-IIB, whereas binding to BMPR-II and ActR-II is not or only partially affected (Weber et al, 2007) . Thus, the molecular mechanisms to generate receptor specificity to either type I or II BMP receptors are diverse throughout the BMP/TGF-b family.
Finally, two single missense mutations, S58T and H59L, in GDF-5 exhibit a surprising relationship between BMP type I receptor-binding affinity and biological activity. Both mutations render the variants inactive in ATDC5-based assays, although their equilibrium binding constants for BMPR-IA are basically unaltered ( Figure 5 ; Supplementary Table III; Supplementary Figure 4) . The unchanged equilibrium-binding constants are a result from a compensatory change in association and dissociation kinetics. Thus, the loss of ALP induction for these two GDF-5 mutants might be related to their shortened complex lifetime due to the increased dissociation rate. Whether a certain complex lifetime is required to allow efficient activation of the intracellular kinases is currently not clear; however, a similar effect has been described for human growth hormone (hGH). Mutations that increase the dissociation rate of hGH from its 'capturing' receptor and hence lower the complex lifetime render hGH inactive (Pearce et al, 1999) . Thus, further investigations are required, but the interesting signalling properties of these two mutants make them valuable tools to study the receptor activation mechanism of GDF-5.
Materials and methods

Recombinant protein expression and purification
The mature part of human GDF-5 and variants thereof were expressed in Escherichia coli and purified from inclusion bodies as described before . For selenomethionine (SeMet) labelling of GDF-5, Met-auxotroph E. coli B834 (DE3) cells (Novagen) carrying the expression plasmid were grown on M9 minimal medium supplemented with 50 mg l À1 (D,L)-Se-Met (Sigma). Similar to BMPR-IA, the BMPR-IB ectodomain was expressed in E. coli as a thioredoxin fusion protein (Kirsch et al, 2000b) . The cells were disrupted by sonication and, after centrifugation, the supernatant was purified using metal ion affinity chromatography (Ni 2 þ -NTA; Qiagen Inc.). After thrombin cleavage, thioredoxin and BMPR-IB proteins were separated by gel filtration chromatography. Monomeric BMPR-IB was collected and further purified by a second metal ion affinity chromatography step. Active BMPR-IB was finally obtained from affinity chromatography employing resin with immobilized BMP-2. Protein purity and homogeneity were analysed by SDS-PAGE and ESI FT-ICR mass spectrometry.
Complex preparation and crystallization
Complex purification and crystallization followed protocols similar to procedures published for BMP-2:BMPR-IA (Kirsch et al, 2000b) . Details of the preparation and crystallization will be published elsewhere. Single crystals of approximately 200 mm Â 100 mm Â 100 mm in size consisting of two BMPR-IB molecules bound to wild-type and Se-Met-labelled GDF-5 dimer, respectively, grew in hanging drops over a reservoir buffer containing 0.1 M sodium acetate pH 5.25, 50% PPG400, 30 mM MgSO 4 within 5 days at 211C.
